Preparedness of public health-care system for Zika virus outbreak: An Indian perspective

Dick, 1952, Zika virus. II. Pathogenicity and physical properties, Trans R Soc Trop Med Hyg, 46, 521, 10.1016/0035-9203(52)90043-6 MacNamara, 1952, Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria, Trans R Soc Trop Med Hyg, 48, 139, 10.1016/0035-9203(54)90006-1 Baud, 2017, An update on Zika virus infection, Lancet, 390, 2099, 10.1016/S0140-6736(17)31450-2 Patterson, 2016, Dengue, Zika and chikungunya: emerging arboviruses in the new world, West J Emerg Med, 17, 671, 10.5811/westjem.2016.9.30904 Duffy, 2009, Zika virus outbreak on Yap Island, federated states of Micronesia, N Engl J Med, 360, 2536, 10.1056/NEJMoa0805715 Shuaib, 2016, Re-emergence of Zika virus: a review on pathogenesis, clinical manifestations, diagnosis, treatment, and prevention, Am J Med, 129, 10.1016/j.amjmed.2016.02.027 Foy, 2011, Probable non-vector borne transmission of Zika virus, Colorado, USA, Emerg Infect Dis, 17, 880, 10.3201/eid1705.101939 Cao-Lormeau, 2014, Zika virus, French Polynesia, South Pacific, 2013, Emerg Infect Dis, 20, 1085, 10.3201/eid2006.140138 Oehler, 2014, Zika virus infection complicated by Guillain–Barre syndrome – case report, French Polynesia, December 2013, Euro Surveill, 19, 10.2807/1560-7917.ES2014.19.9.20720 Zanluca, 2015, First report of autochthonous transmission of Zika virus in Brazil, Mem Inst Oswaldo Cruz, 110, 569, 10.1590/0074-02760150192 Roze, 2016, Zika virus detection in cerebrospinal fluid from two patients with encephalopathy, Martinique, February 2016, Euro Surveill, 21, 30205, 10.2807/1560-7917.ES.2016.21.16.30205 White, 2016, Zika virus: an emergent neuropathological agent, Ann Neurol, 80, 479, 10.1002/ana.24748 Zika virus infection: India. Accessed from: https://www.who.int/emergencies/diseases/zika/india-november-2018/en/ [accessed 25 December 25 2019]. Gatherer, 2016, Zika virus: a previously slow pandemic spreads rapidly through the Americas, J Gen Virol, 97, 269, 10.1099/jgv.0.000381 Lanciotti, 2016, Phylogeny of Zika virus in Western Hemisphere, 2015, Emerg Infect Dis, 22, 933, 10.3201/eid2205.160065 Smithburn, 1954, Neutralizing antibodies against certain viruses in the sera of residents of India, J Immunol, 72, 248, 10.4049/jimmunol.72.4.248 Heyman, 2016, Zika virus and microcephaly: why is this situation a PHEIC?, Lancet, 387, P719, 10.1016/S0140-6736(16)00320-2 Balm, 2012, A diagnostic polymerase chain reaction assay for Zika virus, J Med Virol, 84, 1501, 10.1002/jmv.23241 Fernandes, 2018, Rapid, noninvasive detection of Zika virus in Aedes aegypti mosquitoes by near-infrared spectroscopy, Sci Adv, 4, 10.1126/sciadv.aat0496 Singh, 2019, First report on the transmission of Zika virus by Aedes (Stegomyia) aegypti (L.) (Diptera: Culicidae) during the 2018 Zika outbreak in India, Acta Trop, 199, 105114, 10.1016/j.actatropica.2019.105114 Sapkal, 2018, First laboratory confirmation on the existence of Zika virus disease in India, J Infect, 76, 314, 10.1016/j.jinf.2017.09.020 Yadav, 2019, Zika virus outbreak in Rajasthan, India in 2018 was caused by a virus endemic to Asia, Infect Genet Evol, 69, 199, 10.1016/j.meegid.2019.01.026 Balmaseda, 2018, Comparison of four serological methods and two reverse transcription-PCR assays for diagnosis and surveillance of Zika virus infection, J Clin Microbiol, 56, e01785, 10.1128/JCM.01785-17 Granger, 2017, Serologic testing for Zika virus: comparison of three Zika virus IgM-screening enzyme-linked immunosorbent assays and initial laboratory experiences, J Clin Microbiol, 55, 2127, 10.1128/JCM.00580-17 Pasquier, 2018, Kinetics of anti-ZIKV antibodies after Zika infection using two commercial enzyme-linked immunoassays, Diagn Microbiol Infect Dis, 90, 26, 10.1016/j.diagmicrobio.2017.09.001 Safronetz, 2017, Evaluation of 5 commercially available Zika virus immunoassays, Emerg Infect Dis, 23, 1577, 10.3201/eid2309.162043 Kadkhoda, 2017, Evaluation of a commercially available Zika virus IgM ELISA: specificity in focus, Diagn Microbiol Infect Dis, 88, 233, 10.1016/j.diagmicrobio.2017.04.002 L’Huillier, 2017, Evaluation of euroimmun anti-Zika virus IgM and IgG enzyme-linked immunosorbent assays for Zika virus serologic testing, J Clin Microbiol, 55, 2462, 10.1128/JCM.00442-17 Matheus, 2019, Performance of 2 commercial serologic tests for diagnosing Zika virus infection, Emerg Infect Dis, 25, 1153, 10.3201/eid2506.180361 Lindsey, 2017, Ability to serologically confirm recent Zika virus infection in areas with varying past incidence of dengue virus infection in the United States and U.S. territories in 2016, J Clin Microbiol, 56, 1115, 10.1128/JCM.01115-17 Gourinat, 2015, Detection of Zika virus in urine, Emerg Infect Dis, 21, 84, 10.3201/eid2101.140894 Garcia, 2019, A Zika reference panel for molecular-based diagnostic devices as a US Food and Drug Administration response tool to a public health emergency, J Mol Diagn, 21, 1025, 10.1016/j.jmoldx.2019.06.004 WHO/UNICEF Zika Virus (ZIKV) Vaccine Target Product Profile (TPP): vaccine to protect against congenital Zika syndrome for use during an emergency. Accessed from: https://www.who.int/immunization/research/development/WHO_UNICEF_Zikavac_TPP_Feb2017.pdf [accessed 25 December 2019]. Lee, 2018, Zika virus: from an obscurity to a priority, Microb infect, 20, 635, 10.1016/j.micinf.2018.02.009 Ghaffar, 2018, Fast tracks and roadblocks for Zika vaccines, Vaccines (Basel), 6 Alves, 2018, Research models and tools for the identification of antivirals and therapeutics against Zika virus infection, Viruses, 10, 593, 10.3390/v10110593 Devilliers, 2018, Repurposing drugs for use against Zika virus infection, SAR QSAR Environ Res, 29, 103, 10.1080/1062936X.2017.1411642 Phoo, 2016, Structure of the NS2B-NS3 protease from Zika virus after self-cleavage, Nat Commun, 13410, 10.1038/ncomms13410 Kumar, 2018, Hydroxychloroquine inhibits Zika virus NS2B-NS3 protease, ACS Omega, 31, 18132, 10.1021/acsomega.8b01002 Coronado, 2018, Zika virus NS2B/NS3 proteinase: a new target for an old drug – suramin a lead compound for NS2B/NS3 proteinase inhibition, Antiviral Res, 160, 118, 10.1016/j.antiviral.2018.10.019 D’Aiuto, 2018, R430: a potent inhibitor of DNA and RNA viruses, Sci Rep, 8, 16662, 10.1038/s41598-018-33904-y Cauchemez, 2016, Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study, Lancet, 387, 2125, 10.1016/S0140-6736(16)00651-6 Broutet, 2016, Zika virus as a cause of neurologic disorders, N Engl J Med, 374, 1506, 10.1056/NEJMp1602708 Bhide, 2016, Birth prevalence of microcephaly in India, Bull World Health Organ, 23, 41 Cao-Lormeau, 2016, Guillain–Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case–control study, Lancet, 387, 1531, 10.1016/S0140-6736(16)00562-6 Parra, 2016, Guillain–Barré syndrome associated with zika virus infection in Colombia, N Engl J Med, 375, 1513, 10.1056/NEJMoa1605564 Dirlikov, 2016, Guillain–Barré Syndrome during ongoing zika virus transmission — Puerto Rico, January 1–July 31, 2016, MMWR Morb Mortal Wkly Rep, 65, 910, 10.15585/mmwr.mm6534e1 Garg, 2018, Guillain–Barré syndrome caused by Zika virus: a wake-up call for India, Neurol India, 66, 1290, 10.4103/0028-3886.241356 Baskar, 2018, Antibodies to Zika virus, Campylobacter jejuni, gangliosides in Guillain–Barre syndrome: a prospective single-center study from southern India, Neurol India, 66, 1324, 10.4103/0028-3886.241402 Sumathy, 2017, Protective efficacy of zika vaccine in ag129 mouse model, Sci Rep, 7, 46375, 10.1038/srep46375 Abbink, 2016, Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys, Science, 353, 1129, 10.1126/science.aah6157 Modjarrad, 2017, Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials, Lancet, 391, 563, 10.1016/S0140-6736(17)33106-9 Muthumani, 2016, In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine, NPJ Vaccines, 16021, 10.1038/npjvaccines.2016.21 Tebas, 2017, Safety and immunogenicity of an anti-zika virus DNA vaccine—preliminary report, N Engl J Med, 10.1056/NEJMoa1708120 Dowd, 2016, Rapid development of a DNA vaccine for Zika virus, Science, 354, 237, 10.1126/science.aai9137 Gaudinski, 2018, Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials, Lancet, 391, 552, 10.1016/S0140-6736(17)33105-7 Pardi, 2017, Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination, Nature, 543, 248, 10.1038/nature21428 Richner, 2017, Vaccine mediated protection against zika virus-induced congenital disease, Cell, 170, 273, 10.1016/j.cell.2017.06.040 Nurnberger, 2019, A measles virus-based vaccine candidate mediates protection against Zika virus in an allogeneic mouse pregnancy model, J Virol, 93, 10.1128/JVI.01485-18 Eyer, 2016, Nucleoside inhibitors of Zika virus, J Infect Dis, 214, 707, 10.1093/infdis/jiw226 Furuta, 2009, T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections, Antiviral Res, 82, 95, 10.1016/j.antiviral.2009.02.198 Bullard-Feibelman, 2017, The FDA-approved drug sofosbuvir inhibits Zika virus infection, Antiviral Res, 137, 134, 10.1016/j.antiviral.2016.11.023 Julander, 2017, Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model, Antiviral Res, 137, 14, 10.1016/j.antiviral.2016.11.003 Deng, 2016, Adenosine analog NITD008 is a potent inhibitor of Zika virus, InOpen Forum Infect Dis, 3, 175, 10.1093/ofid/ofw175 Tao, 2018, Design, synthesis and in vitro anti-Zika virus evaluation of novel Sinefungin derivatives, Eur J Med Chem, 157, 994, 10.1016/j.ejmech.2018.08.057 Albulescu, 2017, Suramin inhibits Zika virus replication by interfering with virus attachment and release of infectious particles, Antiviral Res, 143, 230, 10.1016/j.antiviral.2017.04.016 Lim, 2017, Inhibitory effect of flavonoids against NS2B-NS3 protease of ZIKA virus and their structure activity relationship, Biotechnol Lett, 39, 415, 10.1007/s10529-016-2261-6 Roy, 2017, Solution conformations of Zika NS2B-NS3pro and its inhibition by natural products from edible plants, PLOS ONE, 12, 10.1371/journal.pone.0180632 Li, 2017, Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction, Cell Res, 27, 1046, 10.1038/cr.2017.88 Kamiyama, 2017, Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice, Antiviral Res, 146, 1, 10.1016/j.antiviral.2017.08.007 Barrows, 2016, A screen of FDA-approved drugs for inhibitors of Zika virus infection, Cell Host Microbe, 20, 259, 10.1016/j.chom.2016.07.004 Costa, 2017, N-methyl-d-aspartate (NMDA) receptor blockade prevents neuronal death induced by Zika virus infection, MBio, 8, e00350, 10.1128/mBio.00350-17 Xu, 2016, Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen, Nat Med, 22, 1101, 10.1038/nm.4184 Kuivanen, 2017, Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism, Antiviral Res, 139, 117, 10.1016/j.antiviral.2016.12.022 Sarkey, 2007, Lovastatin attenuates nerve injury in an animal model of Guillain–Barré syndrome, J Neurochem, 100, 1265, 10.1111/j.1471-4159.2006.04309.x Adcock, 2017, Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay, Antiviral Res, 138, 47, 10.1016/j.antiviral.2016.11.018 Pascoalino, 2016, Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library, F1000Research, 5 Delvecchio, 2016, Chloroquine, an endocytosis blocking agent, inhibits Zika virus infection in different cell models, Viruses, 8, 322, 10.3390/v8120322